G protein-coupled receptors (GPCRs) constitute a large family of receptor proteins that sense molecular signals on the exterior of a cell and activate signal transduction pathways within the cell. Modeling how an agonist activates such a receptor is fundamental for an understanding of a wide variety of physiological processes and it is of tremendous value for pharmacology and drug design. Inelastic electron tunneling spectroscopy (IETS) has been proposed as a model for the mechanism by which olfactory GPCRs are activated by a bound agonist. We apply this hyothesis to GPCRs within the mammalian nervous system using quantum chemical modeling.
G protein-coupled receptors (GPCRs) constitute a large family of receptor proteins that sense molecular signals on the exterior of a cell and activate signal transduction pathways within the cell. Modeling how an agonist activates such a receptor is fundamental for an understanding of a wide variety of physiological processes and it is of tremendous value for pharmacology and drug design. Inelastic electron tunneling spectroscopy (IETS) has been proposed as a model for the mechanism by which olfactory GPCRs are activated by a bound agonist. We apply this hyothesis to GPCRs within the mammalian nervous system using quantum chemical modeling.
We found that non-endogenous agonists of the serotonin receptor share a particular IET spectral aspect both amongst each other and with the serotonin molecule: a peak whose intensity scales with the known agonist potencies. We propose an experiential validation of this model by utilizing lysergic acid dimethylamide (DAM-57), an ergot derivative, and its deuterated isotopologues; we also provide theoretical predictions for comparison to experiment. If validated our theory may provide new avenues for guided drug design and elevate methods of in silico potency/activity prediction.
Significance Statement
This project provides a scheme by which the potency of small molecule drugs at their target transmembrane receptor may be predicted by a recent theoretical model. This is a vital task as the fundamental mechanism by which receptor proteins are activated via quantum mechanical processes.
INTRODUCTION
Quantum activity within biological systems and the applications of information theory therein have drawn much recent attention [1] [2] [3] [4] [5] . Examples of systems that exploit such phenomenon are: quantum coherence and entanglement in photosynthetic complexes [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] , quantum mutations 16, 17 , information theory and thermodynamics of cancers 18, 19 ,the avian magnetic compass [20] [21] [22] [23] 30 . Although this theory has provided insights into free energy changes associated with the formation of the activated protein/agonist complex, it has not manifested sufficient capacity for the prediction ligand potency due to a lack of knowledge concerning the mechanism by which the agonist activates the complex. Growth of the computational power of modern machines as well as developments within the field of computational chemistry and molecular modeling has afforded reconnaissance and scouting methods in the field of drug design. Additionally methods such as QM/MM have been used in studies of protein folding and generation of the protein-agonist activated complex.
Furthering our ability to predict information regarding the viability of molecules as drugs is greatly important.
Early models attempting to account for predictability of agonist classification beyond mere shape were those of odorant binding 31, 32 ; these works proposed a vibrational theory of receptor activation. Vibrational theories were eventually disregarded for reasons that include a lack of conceived mechanism and the inability of the protein (which undertakes thermally driven random walks in their conformation) to detect the continuum of thermally- 40 . We utilize a model of inelastic electron tunneling to describe the protein/agonist complex in a manner that will utilize the vibrational frequencies of the bound agonist to facilitate electron transfer within the activation site of the protein/agonist complex. The prerequisite agonist information was collected through molecular quantum mechanics calculations utilizing density function theory as well as normal mode analysis and natural bonding order methods; necessary were the harmonic displacements, frequencies and partial charges of each constituent atom. In Section II, we will first present a qualitative discussion of the relationship between the tunneling model and the protein-agonist complex.
Section III will discuss the tunneling features of several 5-HT 1A and 5-HT 2A agonists, and how these correlate with the potency of these molecules taken from previous studies 41? . We conclude with a proposed set of molecules that could be employed in experimental validation of the vibrational theory's applicability in the central nervous system and present the expected results in accordance with this proposed mechanism.
MAPPING THE MODEL INTO THE BIOLOGICAL SYSTEM
Application of the IETS model for the agonists protein environment requires mapping several aspects of the IETS methodology into the biological system. The two-plate apparatus of the tunneling junction herein represent the walls of the receptor site; more explicitly, under electron transfer, the valance and conductance bands associated with each side of the junction are mapped to specific HOMOs and LUMOs of particular residues comprising the walls of the receptor. This dictates that energy transition detectable by the protein should be the energy difference between electronic levels of residue side-chains or any bound cofactors, such as a metal ion. This alteration of IETS also localizes the source of tunneling electrons to a single residue side-chain; the implication is that electrons are not capable of distributed tunneling through the molecule in the manner of a doped analyte within a junction. This lack of a spatial distribution of electron trajectories suggests that the act of tunneling is localized to regions of the agonist molecule along the classical trajectory of the tunneling electron between the site of the electron donor and the site of the electron acceptor. This implies that not all local oscillators associated with a specific mode may fully contribute to the current enhancement due to the fall-off of the charge-dipole coupling between the tunneling electron and the local atomic oscillators.
Secondly, unlike the typical experimental IETS procedure, the analyte is not deposited upon a surface, being encapsulated by the active site. There is no externally applied potential within the receptor site which would have allowed for the scanning of energies; yet, it has been suggested that an ionic cofactor, likely a calcium ion, could provide this driving field. The implication of this is that the receptor is set to test the vibrational-assisted enhancement to the electron tunneling rate at a specific energy, opposed to scanning a range of energies. The electrostatic interactions which govern docking orientation would be a means of orienting the endogenous agonists in such a way that the tunneling junction is appropriately aligned for maximized electron transfer across the atoms responsible for the inelastic contribution. Nonendogenous agonists would align with residues in a manner which may place energetically appropriate vibrational modes of the agonist in proximity of the tunneling vector specific to this protein, thus allowing for the activation of the receptor.
RESULTS
Generation of tunneling spectra was completed through the procedure described by proportional to the Cartesian displacement through the modal center-of-mass factor, √ µ.
This factor arises due to use of center-of-mass coordinates within the classical theory after application of the harmonic approximation during calculations of the normal modes. Natural bond order calculations were performed to yield the partial charges, q i attributed to each atom constituting the agonist. Scaled Kronecker delta functions are plotted at the onresonance absorbance frequency of the mode; these functions were convolved with Gaussian functions possessing a conservative FWHM of 25 cm −1 , representing a very narrow thermal distribution. The spectral width was introduced to allow for peak additions, while 25cm The Spectral Similarity Index of each plot given in the inlay, noting that these similarity indices allude to good spectral agreement with the reference spectrum, LSD. More detailed information is provided within the Supplemental Material
The SI was taken over the entire spectral region and repeated for a scan of the local regions with an overlapping step of 500cm −1 with a width of 1000cm −1 . The SI is given by:
Where, within the above equation, N is the normalization constant (the numerator performed for spectra b and a = b); b i is the value of the spectra being analyzed at discrete location i while a is a reference spectra. Being the most potent agonist, LSD was selected as the reference spectra for our SI calculations. The SIs, both global and local scans, associated with each of the tunneling spectra can be found within a table provided in the Supplementary Material. To highlight major aspects of the tunneling PDF, we squared the function, exaggerating aspects which exhibit large tunneling amplitudes within the spectra (Figure 1 reflected below energy axis) . The only broadly shared spectral aspects were those at 1500cm −1 . For a more thorough discussion of the spectral aspects, isotopic effects at functional groups and density of states for these systems, please see the provided Supplementary Materials.
The integral of the tunneling probability density was taken around the 1500 ± 35cm the non-locality of these oscillators, tunneling probability should be examined after having removed their contributions from the spectra. Figures 2a and 3a present the tunneling spectrum of 2C-T-2 and Aleph-2 disregarding these contributions. After correction for nonlocal motions, the integrals are in good qualitative agreement with the inverse EC50.This preliminary information supports a possible quantum mechanical origin for the activation of sensory proteins. We shall propose a possible experimental validation of the theory within the following section.
PROPOSED EXPERIMENT
Early findings suggest that both the lake whitefish and the American cockroach can identify isotopologues of amino acids and pheromones, respectively 53, 54 DAM-57 (N,N-dimethyllysergamide) is an ergot derivative with a mild hallucinogen effect associated with activity at the 5-HT 2A receptor. As it activates the same receptor, the above discussed candidate peak should, and does, appear in the tunneling spectrum of DAM-57.
By using isotopologues of a single compound, we may minimize any differences which may lead to alterations in either docking geometry or affinity for the activation site. It, however, should be noted that binding isotope effects and kinetic isotope effects can cause differences in the potency of compounds, but this effect rarely outstrips 10% ? so any effect on the order of 30
Using 1500 cm −1 as a central point, and recalling the applied FWHM, the modes contributing to inelastic transfer are those at 1500 ±35 cm This conclusion is supported by the relative activity between DAM-57 and LSD. The flexible ethyl amide of LSD has been found to be essential to its high activity 39, 40, 60, 61 , and that the methyl analogue (DAM-57) is far less potent; the tunneling probability at the 1500 cm −1 region of DAM-57 is depleted when compared to that of LSD. Following this, a prediction that further depletion of the tunneling probability within this region should continue to diminish the potency at the receptor may be entertained. The intensity of the tunneling spectrum of DAM-57-iv is roughly a third the pro-protium, and the probability density of tunneling is roughly tenthed this implies a possible extreme loss of potency associated with deuteration of the amide side-chains.
CONCLUSIONS
Herein we describe the agonist-protein system by an electron tunneling junction coupled to a field of oscillating dipoles, representative of the constituent atoms of the agonist. The oscillator field provides a secondary path for electron transfer between the donor and acceptor states of the junction. This secondary inelastic path facilitates the transfer if and only if the electron can donate a quantum of energy to the oscillator field. Using this method we examined classes of agonists for the 5-HT 2A receptor and found that all agonist, to varying degrees, are capable of facilitating electron transfer within the same energy region. The degree to which this tunneling is facilitated correlates roughly to the potency of the agonist within our test cases. We examined the tunneling characteristics of isotopologues of these agonists and predict that it may be possible to modulate or quench their agonist properties though the isotope exchange of specific atoms. Also included is a proposed experimental path to test the model described herein. We conclude that this mechanism is a candidate for the activation step for some transmembrane proteins, and its examination may allow for better prediction of candidate drug molecules and the possible ability to control agonism of molecules.
